Back to
RA CAPITAL MANAGEMENT, L.P.
ACRSShowing 5 of 13 quarters
Position history for
RA CAPITAL MANAGEMENT, L.P.'s holdings in ACLARIS THERAPEUTICS INC
Yes. RA Capital Management holds 12,723,026 shares of ACRS (Aclaris Therapeutics), worth $67.3M, as of its Q2 2026 13F filing. It increased the position by 5,918,954 shares (+87.0%) from Q1 2026. RA Capital Management has held ACRS since Q1 2026, across 2 quarterly 13F filings. ACRS is 0.6% of RA Capital Management's reported 13F portfolio.
Current Value
$67.3M
Current Shares
12.7M
Total Value Change
+$55.7M
Total Shares Change
+8.1M
Quarter-by-Quarter History
Other major holders of ACRS: WELLINGTON MANAGEMENT GROUP LLP, ADAGE CAPITAL PARTNERS GP, L.L.C.